Derivation of a new human embryonic stem cell line, Endeavour-2, and its characterization

  • Kuldip S. Sidhu
  • John P. Ryan
  • Justin G. Lees
  • Bernard E. Tuch
Article

DOI: 10.1007/s11626-010-9280-8

Cite this article as:
Sidhu, K.S., Ryan, J.P., Lees, J.G. et al. In Vitro Cell.Dev.Biol.-Animal (2010) 46: 269. doi:10.1007/s11626-010-9280-8

Abstract

Here, we describe the derivation of a novel human embryonic stem cell (hESC) line, Endeavour-2 (E-2), propagated on human fetal fibroblasts (HFF) in a serum-replacement media. The inner cell mass (ICM) was manually dissected from the blastocyst without using immunodissection and, therefore, antibodies from animal sources. A total of 20 embryos were thawed and cultured, eight embryos were hatched, and five ICMs were obtained. They were transferred onto HFF used as feeder layer, and one colony representing the initial cell proliferation of a new hESC line, E-2, was obtained. The newly emerged hESC colony was passaged first by physical dissection and subsequently by enzymatic dissociation. E-2 has been in culture for over 6 months and has been shown to possess typical features of a pluripotent hESC line including expression of stem cell surface markers (SSEA4, TRA-160, and integrin alpha-6), intracellular alkaline phosphatase, and pluripotency gene markers, OCT4 and NANOG. This hESC line shows lineage-specific differentiation into various representative cell types expressing markers characteristic of the three somatic germ layers under both in vitro and in vivo conditions. E-2 line shows a normal karyotype (46 XX) and has been successfully cryopreserved and thawed several times using slow-freezing procedures. E-2 adds to the repertoire of existing hESC lines for research and development purposes in the field of regenerative medicine.

Keywords

Pluripotency Teratomas Blastocyst Differentiation 

Copyright information

© The Society for In Vitro Biology 2010

Authors and Affiliations

  • Kuldip S. Sidhu
    • 1
    • 2
  • John P. Ryan
    • 3
  • Justin G. Lees
    • 1
  • Bernard E. Tuch
    • 1
  1. 1.Diabetes Transplant UnitPrince of Wales Hospital & University of New South WalesSydneyAustralia
  2. 2.Stem Cell Lab, School of Biotechnology and Biomolecular Sciences and School of Psychiatry, Faculty of MedicineUniversity of New South WalesSydneyAustralia
  3. 3.IVF AustraliaSydneyAustralia

Personalised recommendations